LABÉO Academy : Artérite virale équine : mieux diagnostiquer pour mieux agir

Value of the Information & Strength of the Argument

The webinar provides valuable, up-to-date information on equine viral arteritis, especially in the context of a recent outbreak. It offers practical guidance for veterinarians and horse owners, covering clinical signs, diagnostic methods, and management strategies. The argumentation is solid, supported by references to scientific studies and regulatory frameworks. The speaker clearly explains complex concepts such as the genetic basis for long-term shedding and the role of testosterone in viral persistence. The presentation is well-structured and addresses both theoretical and practical aspects, making it a useful resource for professionals.

The title accurately reflects the content, focusing on improving diagnosis and management of equine viral arteritis.

8/10

The webinar is presented by a specialized veterinary laboratory (LABÉO) and covers a recent outbreak of equine viral arteritis (EVA) in Normandy, providing detailed clinical, diagnostic, and regulatory information. The content is scientifically grounded, referencing peer-reviewed studies and official regulations. However, it is primarily an expert opinion with practical recommendations, and some claims (e.g., genetic test predictive value) are based on specific studies that may not be universally accepted.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and context of the webinar, mentioning recent cases in Normandy.
• 02:00Overview of EVA as a respiratory and venereal disease, with transmission routes.
• 05:00Clinical signs in stallions, mares, and foals, including abortion and subclinical cases.
• 08:00Explanation of the carrier state in stallions, including short-term and long-term shedders.
• 10:00Discussion of the genetic test for predicting long-term shedding, based on CXCL16 gene.
• 12:00Management strategies for shedding stallions, including castration and GnRH vaccination.
• 15:00Diagnostic methods: PCR and serology, and interpretation of results.
• 18:00Regulatory aspects in France and EU, including testing requirements and export restrictions.
• 21:00Prevention measures: vaccination, biosecurity, and testing new horses.
• 24:00Conclusion and key takeaways.

• Equine viral arteritis: a review — Referenced for general information on EVA.
• Genetic test for long-term shedding in stallions — Mentioned in relation to the genetic test developed by LABÉO and ANSES.
• Study on GnRH vaccination in shedding stallions — Cited as the study by Migać et al. (2020) on chemical castration.

• Equine viral arteritis (Wikipedia) — Provides general information consistent with the webinar.